<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02513121</url>
  </required_header>
  <id_info>
    <org_study_id>2015-4405</org_study_id>
    <nct_id>NCT02513121</nct_id>
  </id_info>
  <brief_title>Dietary Treatment Study of Pediatric NAFLD</brief_title>
  <acronym>DTS</acronym>
  <official_title>Randomized, Controlled Dietary Treatment Study of Pediatric NAFLD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nutrition Science Initiative</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an investigator initiated study being conducted in equal numbers at two sites,
      University of California, San Diego (UC San Diego) and Emory University (EU). The purpose of
      this study is to understand the potential of a low sugar diet for the treatment of
      nonalcoholic fatty liver disease (NAFLD) in children. Forty boys with NAFLD will be randomly
      assigned to either an intervention group or a habitual diet control group. The intervention
      will be a low sugar diet for a period of 8 weeks. The effect of this dietary change will be
      assessed using advanced magnetic resonance imaging (MRI) testing to measure liver fat.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">August 31, 2017</completion_date>
  <primary_completion_date type="Actual">August 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Percentage of Liver Fat Measured by Magnetic Resonance Imaging (MRI) in the Intervention Group Compared to Change in the Control Group</measure>
    <time_frame>Measurements done at baseline and week 8.</time_frame>
    <description>The principal objective of this randomized and controlled pilot study is to evaluate whether 8 weeks of a low added sugar diet (&lt;3%) in boys with NAFLD will change liver fat % measured by MRI.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Alanine Aminotransferase (ALT) From Baseline to Week 8</measure>
    <time_frame>Measurements done at baseline and week 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Aspartate Aminotransferase (AST) From Baseline to Week 8</measure>
    <time_frame>Measurements doen at baseline and week 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Gamma-Glutamyl Transpeptidase (GGT) From Baseline to Week 8</measure>
    <time_frame>Measurements done at baseline and week 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Insulin From Baseline to Week 8</measure>
    <time_frame>Measurements done at baseline and week 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Homeostasis Model Assessment- Insulin Resistance (HOMA-IR) From Baseline to Week 8</measure>
    <time_frame>Measurements done at baseline and week 8</time_frame>
    <description>HOMA-IR was calculated as follows: fasting insulin (µU/mL) x fasting glucose (nmol/L)/22.5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Triglycerides From Baseline to Week 8</measure>
    <time_frame>Measurements done at baseline and week 8</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Nonalcoholic Fatty Liver Disease</condition>
  <arm_group>
    <arm_group_label>Dietary modification</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low free sugar diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Observational Arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dietary modification</intervention_name>
    <description>The intervention is a modification of the family's habitual diet with a low sugar version of their diet.</description>
    <arm_group_label>Dietary modification</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Boys age 11-16 years inclusive.

          -  Clinical history consistent with NAFLD.

          -  Biopsy-proven NAFLD

          -  MRI measured Liver Proton Density Fat Fraction ≥10%

          -  alanine aminotransferase (ALT) ≥ 45 u/L

          -  No evidence of any other liver disease by clinical history or histological evaluation.

          -  Written informed consent from parent or legal guardian.

          -  Written informed assent from the child or adolescent.

        Exclusion Criteria:

        Exclusions will not be based upon gender, race, or ethnicity. Participants with a current
        history of the following conditions or any other health issues that make it unsafe for them
        to participate in the opinion of the Investigators will be excluded from the study:

          -  History of significant alcohol intake (Alcohol Use Disorders Identification Test
             [AUDIT]) or inability to quantify alcohol consumption

          -  Chronic use (more than 2 consecutive weeks) of medications known to cause hepatic
             steatosis or steatohepatitis in the past year.

          -  The use of other known hepatotoxins within 120 days of baseline

          -  History of total parenteral nutrition (TPN) use in the year prior to screening

          -  History of bariatric surgery or planning to undergo bariatric surgery during the study
             duration

          -  Significant depression

          -  Non-compensated liver disease with any one of the following hematologic, biochemical,
             and serological criteria on entry into protocol:

          -  Hemoglobin &lt; 10 g/dL

          -  White blood cell &lt; 3,500 cells/mm

          -  Neutrophil count &lt; 1,500 cells/mm3 of blood

          -  Platelets &lt; 130,000 cells/mm3 of blood

          -  Direct bilirubin &gt; 1.0 mg/dL

          -  Total bilirubin &gt; 3 mg/dL

          -  Albumin &lt; 3.2 g/dL

          -  International normalized ratio (INR) &gt; 1.4

          -  Evidence of other chronic liver disease

          -  Children who are currently enrolled in a clinical trial or who received an
             investigational study drug or a medication with the intent to treat NAFLD/NASH in the
             past 60 days

          -  Contraindications to MRI, e.g. metal in the eyes, implanted electronic devices,
             aneurysm clips, pacemaker, cochlear implants

          -  Unable to have or complete the MRI exam due to body weight exceeding scanner table
             limit or girth exceeding scanner bore diameter

          -  Subjects who are not able or willing to comply with the protocol or have any other
             condition that would impede compliance or hinder completion of the study, in the
             opinion of the investigator

          -  Families with &gt; 5 individuals

          -  Failure to give informed consent
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey B Schwimmer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Miriam Vos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr. 2003 Oct;143(4):500-5.</citation>
    <PMID>14571229</PMID>
  </reference>
  <reference>
    <citation>Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006 Oct;118(4):1388-93.</citation>
    <PMID>17015527</PMID>
  </reference>
  <reference>
    <citation>Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation. 2008 Jul 15;118(3):277-83. doi: 10.1161/CIRCULATIONAHA.107.739920. Epub 2008 Jun 30.</citation>
    <PMID>18591439</PMID>
  </reference>
  <reference>
    <citation>Jin R, Le NA, Liu S, Farkas Epperson M, Ziegler TR, Welsh JA, Jones DP, McClain CJ, Vos MB. Children with NAFLD are more sensitive to the adverse metabolic effects of fructose beverages than children without NAFLD. J Clin Endocrinol Metab. 2012 Jul;97(7):E1088-98. doi: 10.1210/jc.2012-1370. Epub 2012 Apr 27.</citation>
    <PMID>22544914</PMID>
  </reference>
  <reference>
    <citation>Jin R, Welsh JA, Le NA, Holzberg J, Sharma P, Martin DR, Vos MB. Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD. Nutrients. 2014 Aug 8;6(8):3187-201. doi: 10.3390/nu6083187.</citation>
    <PMID>25111123</PMID>
  </reference>
  <reference>
    <citation>Schwimmer JB, Middleton MS, Behling C, Newton KP, Awai HI, Paiz MN, Lam J, Hooker JC, Hamilton G, Fontanesi J, Sirlin CB. Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. Hepatology. 2015 Jun;61(6):1887-95. doi: 10.1002/hep.27666. Epub 2015 Feb 5.</citation>
    <PMID>25529941</PMID>
  </reference>
  <reference>
    <citation>Jin R, Vos MB. Fructose and liver function--is this behind nonalcoholic liver disease? Curr Opin Clin Nutr Metab Care. 2015 Sep;18(5):490-5. doi: 10.1097/MCO.0000000000000203. Review.</citation>
    <PMID>26203597</PMID>
  </reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>July 29, 2015</study_first_submitted>
  <study_first_submitted_qc>July 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 31, 2015</study_first_posted>
  <results_first_submitted>June 26, 2019</results_first_submitted>
  <results_first_submitted_qc>January 16, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 28, 2020</results_first_posted>
  <last_update_submitted>January 16, 2020</last_update_submitted>
  <last_update_submitted_qc>January 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Jeffrey B. Schwimmer, MD</investigator_full_name>
    <investigator_title>Professor of Pediatrics</investigator_title>
  </responsible_party>
  <keyword>NAFLD</keyword>
  <keyword>Steatohepatitis</keyword>
  <keyword>Nonalcoholic Steatohepatitis (NASH)</keyword>
  <keyword>Liver</keyword>
  <keyword>Diet</keyword>
  <keyword>Pediatric</keyword>
  <keyword>Adolescent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified participant data will be made available in response to bona fide and good faith, ad hoc requests. Suitability of each request, if consistent with Institutional Review Board (IRB) approval, will be determined only in the case of a favorable vote of a majority of a committee consisting of each consortium investigator and the Grantor. Data will be made available with a signed access agreement.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 10, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/21/NCT02513121/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 10, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/21/NCT02513121/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Children with NAFLD were recruited from two US academic clinical research centers (University of California, San Diego and Emory University)</recruitment_details>
      <pre_assignment_details>Boys ages 11 - 16 with biopsy proven NAFLD were randomized</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Intervention Group</title>
          <description>Low free sugar diet</description>
        </group>
        <group group_id="P2">
          <title>Control Group</title>
          <description>Habitual diet</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The baseline analysis population includes all participants who consented to participate in the study and met eligibility criteria</population>
      <group_list>
        <group group_id="B1">
          <title>Intervention Group</title>
          <description>Low free sugar diet</description>
        </group>
        <group group_id="B2">
          <title>Control Group</title>
          <description>Habitual diet</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12.8" spread="1.8"/>
                    <measurement group_id="B2" value="13.4" spread="1.9"/>
                    <measurement group_id="B3" value="13.0" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Percentage of Liver Fat Measured by Magnetic Resonance Imaging (MRI) in the Intervention Group Compared to Change in the Control Group</title>
        <description>The principal objective of this randomized and controlled pilot study is to evaluate whether 8 weeks of a low added sugar diet (&lt;3%) in boys with NAFLD will change liver fat % measured by MRI.</description>
        <time_frame>Measurements done at baseline and week 8.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group</title>
            <description>Low free sugar diet</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Habitual diet</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Percentage of Liver Fat Measured by Magnetic Resonance Imaging (MRI) in the Intervention Group Compared to Change in the Control Group</title>
          <description>The principal objective of this randomized and controlled pilot study is to evaluate whether 8 weeks of a low added sugar diet (&lt;3%) in boys with NAFLD will change liver fat % measured by MRI.</description>
          <units>Percentage of liver fat</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.9" lower_limit="18.7" upper_limit="28.0"/>
                    <measurement group_id="O2" value="19.4" lower_limit="16.2" upper_limit="23.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.9" lower_limit="11.4" upper_limit="19.6"/>
                    <measurement group_id="O2" value="18.0" lower_limit="14.0" upper_limit="22.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Alanine Aminotransferase (ALT) From Baseline to Week 8</title>
        <time_frame>Measurements done at baseline and week 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group</title>
            <description>Low free Sugar Diet</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Habitual Diet</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Alanine Aminotransferase (ALT) From Baseline to Week 8</title>
          <units>U/L</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="103.3" lower_limit="79.7" upper_limit="133.8"/>
                    <measurement group_id="O2" value="81.8" lower_limit="63.2" upper_limit="106.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.3" lower_limit="46.1" upper_limit="81.3"/>
                    <measurement group_id="O2" value="75.2" lower_limit="56.7" upper_limit="99.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Aspartate Aminotransferase (AST) From Baseline to Week 8</title>
        <time_frame>Measurements doen at baseline and week 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group</title>
            <description>Low free sugar diet</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Habitual diet</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Aspartate Aminotransferase (AST) From Baseline to Week 8</title>
          <units>U/L</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.0" lower_limit="39.5" upper_limit="68.4"/>
                    <measurement group_id="O2" value="43.6" lower_limit="33.2" upper_limit="57.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.5" lower_limit="27.3" upper_limit="43.6"/>
                    <measurement group_id="O2" value="39.1" lower_limit="31.0" upper_limit="49.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Gamma-Glutamyl Transpeptidase (GGT) From Baseline to Week 8</title>
        <time_frame>Measurements done at baseline and week 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group</title>
            <description>Low free sugar diet</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Habitual diet</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Gamma-Glutamyl Transpeptidase (GGT) From Baseline to Week 8</title>
          <units>U/L</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.3" lower_limit="33.5" upper_limit="58.6"/>
                    <measurement group_id="O2" value="44.1" lower_limit="33.4" upper_limit="58.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.0" lower_limit="26.1" upper_limit="41.6"/>
                    <measurement group_id="O2" value="42.8" lower_limit="33.9" upper_limit="54.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Insulin From Baseline to Week 8</title>
        <time_frame>Measurements done at baseline and week 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group</title>
            <description>Low free sugar diet</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Habitual diet</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Insulin From Baseline to Week 8</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.4" lower_limit="28.6" upper_limit="51.6"/>
                    <measurement group_id="O2" value="41.8" lower_limit="31.2" upper_limit="56.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.7" lower_limit="29.5" upper_limit="48.2"/>
                    <measurement group_id="O2" value="43.8" lower_limit="34.5" upper_limit="55.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Homeostasis Model Assessment- Insulin Resistance (HOMA-IR) From Baseline to Week 8</title>
        <description>HOMA-IR was calculated as follows: fasting insulin (µU/mL) x fasting glucose (nmol/L)/22.5</description>
        <time_frame>Measurements done at baseline and week 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group</title>
            <description>Low free sugar diet</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Habitual diet</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Homeostasis Model Assessment- Insulin Resistance (HOMA-IR) From Baseline to Week 8</title>
          <description>HOMA-IR was calculated as follows: fasting insulin (µU/mL) x fasting glucose (nmol/L)/22.5</description>
          <units>HOMA score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.6" lower_limit="6.3" upper_limit="11.9"/>
                    <measurement group_id="O2" value="9.2" lower_limit="6.7" upper_limit="12.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.7" lower_limit="5.9" upper_limit="10.0"/>
                    <measurement group_id="O2" value="10.2" lower_limit="7.9" upper_limit="13.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Triglycerides From Baseline to Week 8</title>
        <time_frame>Measurements done at baseline and week 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention Group</title>
            <description>Low free sugar diet</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Habitual diet</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Triglycerides From Baseline to Week 8</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="121.7" lower_limit="96.7" upper_limit="153.2"/>
                    <measurement group_id="O2" value="138.9" lower_limit="110.3" upper_limit="174.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="104.1" lower_limit="82.6" upper_limit="131.3"/>
                    <measurement group_id="O2" value="134.3" lower_limit="106.5" upper_limit="169.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event details were collected throughout the duration of study participation, from the Baseline visit through the Week 8 follow up visit.</time_frame>
      <desc>For this study, an adverse event is considered any untoward medical occurrence in a subject participating in a clinical study that does not necessarily have a causal relationship with the dietary intervention.</desc>
      <group_list>
        <group group_id="E1">
          <title>Intervention Group</title>
          <description>Low free sugar diet</description>
        </group>
        <group group_id="E2">
          <title>Control Group</title>
          <description>Habitual diet</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>2.5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Sprained Ankle</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Persistant Cough</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Jeffrey Schwimmer</name_or_title>
      <organization>University of California, San Diego</organization>
      <phone>858-966-8907</phone>
      <email>jschwimmer@ucsd.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

